CelLBxHealth plc (ANPCY) Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation Transcript
Source: SeekingAlpha
2025-12-01 18:53:25 ET
CelLBxHealth plc (ANPCY) Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
CelLBxHealth plc (ANPCY) Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation Transcript
Angle
NASDAQ: ANPCF
ANPCF Trading
-0.07% G/L:
$0.0137 Last:
4,010 Volume:
$0.01371 Open:
ANPCF Latest News
January 16, 2026 02:26:00 am
CelLBxHealth PLC Announces Preliminary Fourth Quarter 2025 Financial Results
ANPCF Stock Data
$5,420,380
237,609,904
3.4%
1
N/A
Medical Diagnostics & Screening
Healthcare
GB
Guildford
